Answer
Eravacycline exposure in utero during the second and third trimesters may cause permanent dental defects (discolouration and enamel defects) and delayed ossification, although human pregnancy data are limited and the potential human risk is unknown.
Sources for this answer
- Xerava 100 mg powder for concentrate for solution for infusionPAION UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked